Modelli di dati selezionati

Devi effettuare il log in per selezionare i modelli di dati da scaricare per successive analisi

49 Risultati di ricerca.
rilevanza Valutazione Più recente Meno recente

Eligibility Acute Lymphoblastic Leukemia NCT01744223

- 21/12/15 - 1 modulo, 2 itemgroups, 15 elementi, 1 linguaggio
Itemgroups: Inclusion Criteria, Exclusion Criteria
Safety Study of Gene Modified Donor T-cells Following Partially Mismatched Stem Cell Transplant; ODM derived from: https://clinicaltrials.gov/show/NCT01744223

Eligibility Acute Lymphoblastic Leukemia NCT00861679

- 21/12/15 - 1 modulo, 2 itemgroups, 14 elementi, 1 linguaggio
Itemgroups: Inclusion Criteria, Exclusion Criteria
Therapy Protocol Acute Lymphoblastic Leukemia Stem Cell Transplantation International; ODM derived from: https://clinicaltrials.gov/show/NCT00861679

Eligibility Acute Lymphoblastic Leukemia NCT00529360

- 21/12/15 - 1 modulo, 2 itemgroups, 15 elementi, 1 linguaggio
Itemgroups: Inclusion Criteria, Exclusion Criteria
Allogeneic Stem Cell Transplant With Clofarabine, Ara-C and TBI for AML and ALL; ODM derived from: https://clinicaltrials.gov/show/NCT00529360

Eligibility Acute Lymphoblastic Leukemia NCT00368355

- 21/12/15 - 1 modulo, 2 itemgroups, 17 elementi, 1 linguaggio
Itemgroups: Inclusion Criteria, Exclusion Criteria
T Cell Depletion for Recipients of HLA Haploidentical Related Donor Stem Cell Grafts; ODM derived from: https://clinicaltrials.gov/show/NCT00368355

Eligibility Acute Lymphoblastic Leukaemia NCT01949129

- 07/12/15 - 1 modulo, 2 itemgroups, 19 elementi, 1 linguaggio
Itemgroups: Inclusion Criteria, Exclusion Criteria
Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leukaemia; ODM derived from: https://clinicaltrials.gov/show/NCT01949129

Eligibility Acute Leukemias NCT01339988

- 07/12/15 - 1 modulo, 2 itemgroups, 13 elementi, 1 linguaggio
Itemgroups: Inclusion Criteria, Exclusion Criteria
Busulfan and Cyclophosphamide Instead of Total Boby Irradiation (TBI) and Cyclophosphamide for Hematological Malignancies Hematocrit (HCT); ODM derived from: https://clinicaltrials.gov/show/NCT01339988

Day of last Dose-Toxicity Stem-Cell Transplantation CASLAMB NCT00148148

- 07/12/15 - 1 modulo, 10 itemgroups, 26 elementi, 2 lingue
Itemgroups: Allergy, Patient condition, Skin, Gastrointestinal, Hepatic, Metabolic / Laboratory, Pulmonary, Pain, Renal/Genitourinary, Appendix VI: BMT complex
A Study of Caspofungin, Liposomal Amphotericin B or the Combination of Both for Patients After Stem-Cell Transplantation NCT00148148

Baseline-Medication Stem-Cell Transplantation CASLAMB NCT00148148

- 07/12/15 - 1 modulo, 5 itemgroups, 16 elementi, 2 lingue
Itemgroups: Medication, Amphotericin B, Caspofungin, Blood samples for the analysis of plasma concentrations, Date and signature
A Study of Caspofungin, Liposomal Amphotericin B or the Combination of Both for Patients After Stem-Cell Transplantation NCT00148148

Baseline-Toxicity Stem-Cell Transplantation CASLAMB NCT00148148

- 07/12/15 - 1 modulo, 10 itemgroups, 26 elementi, 2 lingue
Itemgroups: Hypersensitivity, Patient condition, Skin, Gastrointestinal, Hepatic, Metabolic/Laboratory, Pulmonary, Pain, Renal/Genitourinary, Appendix VI: BMT complex
A Study of Caspofungin, Liposomal Amphotericin B or the Combination of Both for Patients After Stem-Cell Transplantation NCT00148148

Days 2-5 Toxicity Stem-Cell Transplantation CASLAMB NCT00148148

- 06/12/15 - 1 modulo, 10 itemgroups, 26 elementi, 2 lingue
Itemgroups: Allergy, Patient condition, Skin, Gastrointestinal, Hepatic, Metabolic/ Laboratory, Pulmonary, Pain, Renal/ Genitourinary, Appendix VI: BMT complex
A Study of Caspofungin, Liposomal Amphotericin B or the Combination of Both for Patients After Stem-Cell Transplantation NCT00148148

Study Completion-Toxicity Stem-Cell Transplantation CASLAMB NCT00148148

- 06/12/15 - 1 modulo, 10 itemgroups, 26 elementi, 2 lingue
Itemgroups: Allergy, Patient condition, Skin, Gastrointestinal, Hepatic, Metabolic/ Laboratory, Pulmonary, Pain, Renal / Genitourinary system, Appendix VI: BMT complex
A Study of Caspofungin, Liposomal Amphotericin B or the Combination of Both for Patients After Stem-Cell Transplantation NCT00148148

Day of last Dose-Imaging Stem-Cell Transplantation CASLAMB NCT00148148

- 02/12/15 - 1 modulo, 5 itemgroups, 16 elementi, 2 lingue
Itemgroups: Chest X-ray, HR-CT of the lungs, Other methods, Other examinations, Detection of infection status
A Study of Caspofungin, Liposomal Amphotericin B or the Combination of Both for Patients After Stem-Cell Transplantation NCT00148148

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial